Enliven Therapeutics (ELVN) Stock Price
Enliven Therapeutics Price
The consensus 12-month price target for Enliven Therapeutics is 78.00 USD, about 54.8% above where the stock trades today. Of 21 analysts, 20 rate the stock a buy — an overall Buy consensus.
Enliven Therapeutics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Enliven Therapeutics business model & stock analysis
Frequently asked questions about Enliven Therapeutics
Analysts currently set an average price target of 76.00 USD for the Enliven Therapeutics stock (median: 78.00 USD), implying +50.9 % versus the latest price. The consensus is based on 21 analyst ratings.
21 analysts currently rate the Enliven Therapeutics stock: 20 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Enliven Therapeutics to generate revenue of 10,000.00 USD and earnings per share of -1.95 USD.
Converted at the current exchange rate, the Enliven Therapeutics share trades at 45.04 EUR (50.38 USD).
The Enliven Therapeutics share (ELVN) is listed on 1 stock exchanges, including: NASDAQ (ELVN).
The expected revenue of Enliven Therapeutics is 10,000.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Enliven Therapeutics is -110.21 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Enliven Therapeutics is currently -25.90. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Enliven Therapeutics stock.
The price-to-sales ratio (P/S) of Enliven Therapeutics is currently 285,474.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Enliven Therapeutics stock.
The Eulerpool Quality Score for Enliven Therapeutics is 3/10.
The ISIN of Enliven Therapeutics is US29337E1029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Enliven Therapeutics is ELVN. The ticker symbol is used to trade Enliven Therapeutics shares on the stock exchange.
Enliven Therapeutics stock
Enliven Therapeutics Peer Group
Enliven Therapeutics Ticker
Enliven Therapeutics FIGI
All fundamentals and in-depth analysis of Enliven Therapeutics
Our stock analysis for Enliven Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enliven Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.